title: A Review of Methamphetamine Dependence and Withdrawal Treatment: A Focus on Anxiety Outcomes.
abstract: Rates of anxiety disorders among individuals who use methamphetamine are estimated to be as high as 30.2%. The presence of an anxiety disorder in methamphetamine users is associated with higher rates of relapse, non-adherence to treatment and poorer outcomes relative to methamphetamine users without an anxiety disorder. A review investigating current treatment options for methamphetamine dependence or withdrawal from methamphetamine was conducted using PubMed, CINAHL and PsycINFO. The focus of the review was trials that utilized an intervention and collected anxiety as an outcome measure. Seven studies were included in the review, and five of these studies examined a pharmacotherapy option, one studied a psychosocial intervention and one study investigated exercise as an intervention. Some of the pharmacotherapy studies and the study of exercise were associated with improvements in mood and/or a reduction in methamphetamine use. Concerns of sample size and measurement of anxiety were raised. Future well-designed research with large sample sizes is warranted to examine how to manage anxiety among methamphetamine users.
authors: Montana State University College of Nursing, Missoula, MT 59812-7416, United States. Electronic address: tracy.hellem1@montana.edu.
authors: Tracy L
authors: TL
authors: Hellem
mesh_terms: D019969:Amphetamine-Related Disorders / Q000628:therapy*; D001008:Anxiety Disorders; D000697:Central Nervous System Stimulants; D006801:Humans; D008694:Methamphetamine; D017063:Outcome Assessment, Health Care; D013375:Substance Withdrawal Syndrome / Q000628:therapy*
chemical_list: D000697:Central Nervous System Stimulants; D008694:Methamphetamine
keywords: Anxiety; Comorbid disorders; Depression; Methamphetamine use disorders; Treatment options